Detalles de la búsqueda
1.
Efficacy and safety of risankizumab for Crohn's disease in patients from Asian countries: a post hoc subanalysis of the global phase 3 ADVANCE, MOTIVATE, and FORTIFY studies.
J Gastroenterol Hepatol
; 39(1): 55-65, 2024 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-37788676
2.
Risankizumab as maintenance therapy for moderately to severely active Crohn's disease: results from the multicentre, randomised, double-blind, placebo-controlled, withdrawal phase 3 FORTIFY maintenance trial.
Lancet
; 399(10340): 2031-2046, 2022 05 28.
Artículo
en Inglés
| MEDLINE | ID: mdl-35644155
3.
Risankizumab as induction therapy for Crohn's disease: results from the phase 3 ADVANCE and MOTIVATE induction trials.
Lancet
; 399(10340): 2015-2030, 2022 05 28.
Artículo
en Inglés
| MEDLINE | ID: mdl-35644154
4.
The 3'UTR of the α6 integrin message regulates localization of α6ß4 integrin heterodimers.
Biochem Biophys Res Commun
; 513(1): 8-14, 2019 05 21.
Artículo
en Inglés
| MEDLINE | ID: mdl-30922568
5.
Impact of upadacitinib induction and maintenance therapy on health-related quality of life, fatigue, and work productivity in patients with moderately-to-severely active Crohn's disease.
J Crohns Colitis
; 2024 Jun 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-38835235
6.
Maintenance Risankizumab Sustains Induction Response in Patients with Crohn's Disease in a Randomized Phase 3 Trial.
J Crohns Colitis
; 18(3): 416-423, 2024 Mar 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-37797293
7.
Laminin-332 and α3ß1 integrin-supported migration of bronchial epithelial cells is modulated by fibronectin.
Am J Respir Cell Mol Biol
; 49(5): 731-40, 2013 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-23590307
8.
α6ß4 integrin, a master regulator of expression of integrins in human keratinocytes.
J Biol Chem
; 287(22): 17975-84, 2012 May 25.
Artículo
en Inglés
| MEDLINE | ID: mdl-22493440
9.
Dose Escalation Patterns of Advanced Therapies in Crohn's Disease and Ulcerative Colitis: A Systematic Literature Review.
Adv Ther
; 40(5): 2051-2081, 2023 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-36930430
10.
Matching-Adjusted Indirect Comparison Between Risankizumab and Ustekinumab for Induction and Maintenance Treatment of Moderately to Severely Active Crohn's Disease.
Adv Ther
; 40(9): 3896-3911, 2023 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-37368103
11.
Efficacy, Safety, Patient Experience, and Tolerability of Risankizumab Administered by On-Body Injector for Moderate to Severe Crohn's Disease.
Adv Ther
; 40(5): 2311-2325, 2023 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-36917429
12.
Risankizumab Induction Therapy Achieves Early Symptom Improvements That Are Associated With Future Clinical and Endoscopic Outcomes in Crohn's Disease: Post Hoc Analysis of the ADVANCE, MOTIVATE, and FORTIFY Phase 3 Studies.
J Crohns Colitis
; 2023 Dec 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-38069472
13.
Laminin deposition in the extracellular matrix: a complex picture emerges.
J Cell Sci
; 122(Pt 24): 4409-17, 2009 Dec 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-19955338
14.
A Global, Prospective, Observational Study Measuring Disease Burden and Suffering in Patients with Ulcerative Colitis Using the Pictorial Representation of Illness and Self-Measure Tool.
J Crohns Colitis
; 2020 Jul 29.
Artículo
en Inglés
| MEDLINE | ID: mdl-32722760
15.
Association of Biomarker Cutoffs and Endoscopic Outcomes in Crohn's Disease: A Post Hoc Analysis From the CALM Study.
Inflamm Bowel Dis
; 26(10): 1562-1571, 2020 09 18.
Artículo
en Inglés
| MEDLINE | ID: mdl-32105310
16.
14-3-3zeta/tau heterodimers regulate Slingshot activity in migrating keratinocytes.
Biochem Biophys Res Commun
; 383(4): 450-4, 2009 Jun 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-19371722
17.
Rapid Changes in Laboratory Parameters and Early Response to Adalimumab: A Pooled Analysis From Patients With Ulcerative Colitis in Two Clinical Trials.
J Crohns Colitis
; 13(9): 1227-1233, 2019 Sep 19.
Artículo
en Inglés
| MEDLINE | ID: mdl-30726897
18.
Fluorescently tagged laminin subunits facilitate analyses of the properties, assembly and processing of laminins in live and fixed lung epithelial cells and keratinocytes.
Matrix Biol
; 27(7): 640-7, 2008 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-18617003
19.
Flii control: balancing migration and adhesion.
J Invest Dermatol
; 129(8): 1856-8, 2009 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-19603052
20.
The slingshot family of phosphatases mediates Rac1 regulation of cofilin phosphorylation, laminin-332 organization, and motility behavior of keratinocytes.
J Biol Chem
; 282(44): 32520-8, 2007 Nov 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-17848544
Resultados
1 -
20
de 20
1
Próxima >
>>